Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.

The epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a ...

Managing blood pressure can protect your heart, brain, and more. These strategies can help you keep your BP under control.

Drinking enough water may reduce period pain, bloating, and fatigue. Learn how hydration influences hormones and menstrual ...

Mineralys Therapeutics leads a biotech surge, with four drug stocks up over 50% in 2025 and catalysts lining up for more ...

MLYS, LYEL, NKTR and INSM rise more than 50% in 2025 as clinical wins, FDA approvals and M&A deals revive sector momentum heading into 2026.

The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...

Adrenal glands produce hormones that affect heart rate, blood pressure, and stress response. High cortisol levels can cause ...

Major updates from the American Heart Association demand stricter sodium limits and specific isometric exercises to fight hypertension. Discover the 2025 blueprint that links lower blood pressure to a ...